Videos
Benefits of Dual Treatment for MCL
12/09/2020
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Subscribe and Stay Ahead With Daily Industry Insights
First Report Managed Care Newsletter